Obermatt
See Similar Stocks →

Flags

Financial distress

Healius

ASX:HLS · AU0000033359
Health Care Providers & ServicesMedium

360

20
EV / EBIT39
Price / Owner Earnings59
Owner Earnings Yield1
Dividend Yield33
Price/Sales91
EV / Gross Profit69
Price/Book95
Return on Capital34
Cash Return on Capital20
Return on Equity6
EBIT Margin36
Gross Profitability35
Accruals100
Owner Earnings Margin18
Sales growth13
Profit Growth9
Long-Term EPS Growth92
Reinvestment7
Price momentum1
Debt load7
Refinancing8
Debt Payback1
Liquidity20
Analyst ratings1
Opinion Changes62
Price Target Upside70
Market mood3
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Healius doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeASX
Founded1994
Employees817
Websitehealius.com.au
ISINAU0000033359
Last UpdateApr 2, 2026
Indices
ASX 300 (Australia)
Themes
Health DiagnosticsGeneticsHealth CareHospitalMedical

Description

Healius Limited is a healthcare company based in Australia that specializes in providing vital pathology and imaging services. The company's operations center around improving health outcomes for patients through innovative diagnostic solutions. Its…

Analysis

Middle-of-the-road

Healius Limited sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is stretched. The company scores 6/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
4
2023202420252026

All-time high

71

Jan 2023

All-time low

1

Mar 2026

Average rank

16

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
91
79
83
71
Price/Earnings
96
5
27
95
Price/Book
95
83
93
69
Dividend Yield
33
16
36
62
Value (overall)
94
37
63
83

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Healius with its peers
Australian Clinical Labs
ASX:ACL
65
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Sonic
ASX:SHL
36
CountryAustralia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Ebos
NZC:EBO
40
CountryAustralia
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Shinhung
KSC:004080
60
CountrySouth Korea
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Prenetics Global
NMQ:PRE
52
CountryHong Kong SAR China
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Integral Diagnostics
ASX:IDX
45
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →